No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: A nested case-control study

被引:27
作者
Korodi, Z
Wang, XH
Tedeschi, R
Knekt, P
Dillner, J
机构
[1] Malmo Univ Hosp, Dept Med Microbiol, Univ Lund, Malmo, Sweden
[2] Ctr Rihiurerimento Oncol Aviano, Microbiol Immunol & Virol Dept, Aviano, Italy
[3] Natl Publ Hlth Inst, Helsinki, Finland
关键词
D O I
10.1086/430354
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sexual history has consistently been found to be a risk factor for the development of prostate cancer. An association between prostate cancer and herpes simplex virus type 2 (HSV2) or Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 (HHV-8) infections has also been reported. Linkage of data on a cohort of 20,243 healthy Finnish men identified 165 cases of prostate cancer that were diagnosed up to 24 years after donation of a serum sample. Two control subjects were matched by age, sex, and municipality of residence to each case patient. Serum levels of immunoglobulin G against HSV-2 and HHV-8 were determined. Neither HSV2 infection ( odds ratio [ OR], 0.93 [95% confidence interval {CI}, 0.44 - 1.96]) nor HHV-8 infection (OR, 0.74 [95% CI, 0.19 - 2.88]) was associated with prostate cancer.
引用
收藏
页码:2008 / 2011
页数:4
相关论文
共 16 条
[1]  
Adami HO, 2003, CANCER EPIDEM BIOMAR, V12, P872
[2]   THE RELATIONSHIP OF HERPESVIRUS TO CARCINOMA OF THE PROSTATE [J].
BAKER, LH ;
MEBUST, WK ;
CHIN, TDY ;
CHAPMAN, AL ;
HINTHORN, D ;
TOWLE, D .
JOURNAL OF UROLOGY, 1981, 125 (03) :370-374
[3]  
Dillner J, 1998, INT J CANCER, V75, P564, DOI 10.1002/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO
[4]  
2-9
[5]   Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels [J].
Grabowska, K ;
Wang, XH ;
Jacobsson, A ;
Dillner, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 271 (1-2) :1-15
[6]   IMMUNOFLUORESCENT EVIDENCE OF PRIOR HERPES-SIMPLEX VIRUS TYPE-2 INFECTION IN PROSTATE CARCINOMA [J].
HAID, M ;
SHARON, N .
UROLOGY, 1984, 24 (06) :623-625
[7]   Sexual behaviour, STDs and risks for prostate cancer [J].
Hayes, RB ;
Pottern, LM ;
Strickler, H ;
Rabkin, C ;
Pope, V ;
Swanson, GM ;
Greenberg, RS ;
Schoenberg, JB ;
Liff, J ;
Schwartz, AG ;
Hoover, RN ;
Fraumeni, JF .
BRITISH JOURNAL OF CANCER, 2000, 82 (03) :718-725
[8]   Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer [J].
Hoffman, LJ ;
Bunker, CH ;
Pellett, PE ;
Trump, DL ;
Patrick, AL ;
Dollard, SC ;
Keenan, HA ;
Jenkins, FJ .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (01) :15-20
[9]   Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma [J].
Katano, H ;
Iwasaki, T ;
Baba, N ;
Terai, M ;
Mori, S ;
Iwamoto, A ;
Kurata, T ;
Sata, T .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3478-3485
[10]   SERUM VITAMIN-E AND RISK OF CANCER AMONG FINNISH MEN DURING A 10-YEAR FOLLOW-UP [J].
KNEKT, P ;
AROMAA, A ;
MAATELA, J ;
AARAN, RK ;
NIKKARI, T ;
HAKAMA, M ;
HAKULINEN, T ;
PETO, R ;
SAXEN, E ;
TEPPO, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (01) :28-41